Literature DB >> 15138155

Defect in glucokinase translocation in Zucker diabetic fatty rats.

Yuka Fujimoto1, E Patrick Donahue, Masakazu Shiota.   

Abstract

Hepatic glucose fluxes and intracellular movement of glucokinase (GK) in response to increased plasma glucose and insulin were examined in 10-wk-old, 6-h-fasted, conscious Zucker diabetic fatty (ZDF) rats and lean littermates. Under basal conditions, plasma glucose (mmol/l) and glucose turnover rate (GTR; micromol.kg(-1).min(-1)) were slightly higher in ZDF (8.4 +/- 0.3 and 53 +/- 7, respectively) than in lean rats (6.2 +/- 0.2 and 45 +/- 4, respectively), whereas plasma insulin (pmol/l) was higher in ZDF (1,800 +/- 350) than in lean rats (150 +/- 14). The ratio of hepatic uridine 5'-diphosphate-glucose 3H specific activity to plasma glucose 3H specific activity ([3H]UDP-G/[3H]G; %), total hepatic glucose output (micromol.kg(-1).min(-1)), and hepatic glucose cycling (micromol.kg(-1).min(-1)) were higher in ZDF (35 +/- 5, 87 +/- 16, and 33 +/- 10, respectively) compared with lean rats (18 +/- 3, 56 +/- 6, and 11 +/- 2, respectively). [3H]glucose incorporation into glycogen (micromol glucose/g liver) was similar in lean (1.0 +/- 0.7) and ZDF (1.6 +/- 0.8) rats. GK was predominantly located in the nucleus in both rats. With elevated plasma glucose and insulin, GTR (micromol.kg(-1).min(-1)), [3H]UDP-G/[3H]G (%), and [3H]glucose incorporation into glycogen (micromol glucose/g liver) were markedly higher in lean (191 +/- 22, 62 +/- 3, and 5.0 +/- 1.4, respectively) but similar in ZDF rats (100 +/- 6, 37 +/- 3, and 1.4 +/- 0.4, respectively) compared with basal conditions. GK translocation from the nucleus to the cytoplasm occurred in lean but not in ZDF rats. The unresponsiveness of hepatic glucose flux to the rise in plasma glucose and insulin seen in prediabetic ZDF rats was associated with impaired GK translocation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138155     DOI: 10.1152/ajpendo.00575.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  14 in total

1.  Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein.

Authors:  Ke Wu; David Cappel; Melissa Martinez; John M Stafford
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

3.  Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.

Authors:  Kiichiro Ueta; Tracy P O'Brien; Gregory A McCoy; Kuikwon Kim; Erin C Healey; Tiffany D Farmer; E Patrick Donahue; Audree B Condren; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-08       Impact factor: 4.310

4.  A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes in vivo.

Authors:  Jian Hua Li; Shalini Jain; Sara M McMillin; Yinghong Cui; Dinesh Gautam; Wataru Sakamoto; Huiyan Lu; William Jou; Owen P McGuinness; Oksana Gavrilova; Jürgen Wess
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

5.  Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.

Authors:  David J Lloyd; David J St Jean; Robert J M Kurzeja; Robert C Wahl; Klaus Michelsen; Rod Cupples; Michelle Chen; John Wu; Glenn Sivits; Joan Helmering; Renée Komorowski; Kate S Ashton; Lewis D Pennington; Christopher Fotsch; Mukta Vazir; Kui Chen; Samer Chmait; Jiandong Zhang; Longbin Liu; Mark H Norman; Kristin L Andrews; Michael D Bartberger; Gwyneth Van; Elizabeth J Galbreath; Steven L Vonderfecht; Minghan Wang; Steven R Jordan; Murielle M Véniant; Clarence Hale
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

6.  Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Yuka Fujimoto; E P Donahue; Richard L Printz; Karen L Houseknecht; Judith L Treadway; Masakazu Shiota
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

7.  CETP Expression Protects Female Mice from Obesity-Induced Decline in Exercise Capacity.

Authors:  David A Cappel; Louise Lantier; Brian T Palmisano; David H Wasserman; John M Stafford
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

8.  Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Reetta L Catlin; Robert Chan; Yuka Fujimoto; Noriyasu Sasaki; Richard L Printz; Christopher B Newgard; Masakazu Shiota
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

9.  Tpk3 and Snf1 protein kinases regulate Rgt1 association with Saccharomyces cerevisiae HXK2 promoter.

Authors:  A Palomino; P Herrero; F Moreno
Journal:  Nucleic Acids Res       Date:  2006-03-09       Impact factor: 16.971

10.  A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.

Authors:  Matthew G Rees; Mindy I Davis; Min Shen; Steve Titus; Anne Raimondo; Amy Barrett; Anna L Gloyn; Francis S Collins; Anton Simeonov
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.